Humanization of antibodies

被引:158
作者
Almagro, Juan C. [1 ]
Fransson, Johan [2 ]
机构
[1] Centocor Inc, R&D, Radnor, PA 19087 USA
[2] Centocor Discovery Res, San Diego, CA 92121 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词
immunoglobulins; Igs; hypervariable loops; framework; FR; complementarity determining regions; CDR; SRD; canonical structures; CDR grafting; SDR grafting Resurfacing; Superhumanization; Guided Selection; Humaneering; Framework Shuffling; review;
D O I
10.2741/2786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humanization has played a fundamental role in the remarkable progress of antibodies as therapeutic reagents. Here we have reviewed the publications on antibody humanization since the first report on CDR grafting in the second half of the 1980's up to June 2007. We describe the two main trends in the field: rational and empirical methods to humanize antibodies. Rational methods rely on the so-called design cycle. It consists of generating a small set of variants, which are designed based on the antibody structure and/or sequence information, and assessing their binding or any other characteristic of interest. Rational methods include CDR grafting, Resurfacing, Superhumanization and Human String Content Optimization. In contrast to rational methods, empirical methods are based on generating large combinatorial libraries and selecting the desired variants by enrichment technologies such as phage, ribosome or yeast display, or by high throughput screening techniques. The latter methods rest on selection rather than making assumptions on the impact of mutations on the antibody structure. These methods include Framework Libraries, Guided Selection, Framework Shuffling and Humaneering.
引用
收藏
页码:1619 / 1633
页数:15
相关论文
共 109 条
[91]   Structural correlates of an anticarcinoma antibody: Identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only [J].
Tamura, M ;
Milenic, DE ;
Iwahashi, M ;
Padlan, E ;
Schlom, J ;
Kashmiri, SVS .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1432-1441
[92]   Superhumanized antibodies: Reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: Application to an anti-CD28 [J].
Tan, P ;
Mitchell, DA ;
Buss, TN ;
Holmes, MA ;
Anasetti, C ;
Foote, J .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :1119-1125
[93]   IDENTIFICATION OF FRAMEWORK RESIDUES REQUIRED TO RESTORE ANTIGEN-BINDING DURING RESHAPING OF A MONOCLONAL-ANTIBODY AGAINST THE GLYCOPROTEIN GB OF HUMAN CYTOMEGALOVIRUS [J].
TEMPEST, PR ;
WHITE, P ;
BUTTLE, M ;
CARR, FJ ;
HARRIS, WJ .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1995, 17 (01) :37-42
[94]   The imprint of somatic hypermutation on the repertoire of human germline V genes [J].
Tomlinson, IM ;
Walter, G ;
Jones, PT ;
Dear, PH ;
Sonnhammer, ELL ;
Winter, G .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 256 (05) :813-817
[95]   SOMATIC GENERATION OF ANTIBODY DIVERSITY [J].
TONEGAWA, S .
NATURE, 1983, 302 (5909) :575-581
[96]   STRUCTURAL DETERMINANTS OF THE CONFORMATIONS OF MEDIUM-SIZED LOOPS IN PROTEINS [J].
TRAMONTANO, A ;
CHOTHIA, C ;
LESK, AM .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (04) :382-394
[97]   FRAMEWORK RESIDUE-71 IS A MAJOR DETERMINANT OF THE POSITION AND CONFORMATION OF THE 2ND HYPERVARIABLE REGION IN THE VH DOMAINS OF IMMUNOGLOBULINS [J].
TRAMONTANO, A ;
CHOTHIA, C ;
LESK, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (01) :175-182
[98]   RESHAPING HUMAN-ANTIBODIES - GRAFTING AN ANTILYSOZYME ACTIVITY [J].
VERHOEYEN, M ;
MILSTEIN, C ;
WINTER, G .
SCIENCE, 1988, 239 (4847) :1534-1536
[99]   Humanization of a mouse monoclonal antibody neutralizing TNF-α by guided selection [J].
Wang, ZZ ;
Wang, Y ;
Li, ZF ;
Li, J ;
Dong, ZW .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 241 (1-2) :171-184
[100]   Guided selection of antibody fragments specific for human interferon γ receptor 1 from a human VH- and VL-gene repertoire [J].
Watzka, H ;
Pfizenmaier, K ;
Moosmayer, D .
IMMUNOTECHNOLOGY, 1998, 3 (04) :279-291